Home Treatment for Individuals Suffering From Severe Addictive Disorders

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorLouise Penzenstadler

About this trial

Home Treatment (HT) has been successfully implemented in adult psychiatry in several countries including Switzerland. Patients with addiction problems were generally excluded even if the latter was not the main diagnosis. On the other hand, community treatments have successfully been established for these individuals. The investigators have recently offered HT to persons with severe addictive disorders which was well accepted.

The investigators intend to conduct a pilot study to prepare a large-scale study if successful. The investigators intend to compare HT to treatment as usual (regular inpatient treatment) on a specialized ward with respect to readmission rates during 6 months after discharge. The data show that 70.8% of all readmissions occur during the first 6 months. Therefore, a period of 6 months is considered an adequate time interval to sufficiently answer this pilot study's question.

Eligibility criteria

Qualifiers

Substance use disorder

age 18 or above

sufficient french language skills

competent subjects

Disqualifiers

organic brain disease or developmental disorder

non voluntary admission

severe somatic comorbidity

History of complicated substance withdrawal

Trial design

Treatments tested in this trial

  • Hospital-like treatment in patients' home
  • standard inpatient treatment

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Louise Penzenstadler

Lead sponsor

University Hospital, Geneva

Sponsor institution